Nowhere is patent protection more important than in the pharmaceutical industry. Our pharmaceutical patent practice is second to none, and we have a concentration of pharmaceutical patent expertise that is envied by our competitors. We represent many of the world's major pharmaceutical companies.

These clients repeatedly entrust us with cases involving their most valuable intellectual property, the patents on blockbuster drugs that are vital to their continued growth. We have been involved in representing branded pharmaceutical companies in defending against generic challengers for more than 20 years, and we believe that we have handled as many ANDA-based litigations as any other firm. We have advised clients, not only on responding to an ANDA challenge after one is received, but also in preparing well in advance to meet such challenges. We have litigated patents in virtually every field of medicine, including such diverse areas as anti-infectives, anti-psychotics, oncologics, cardiovascular drugs, fertility control, hormone replacement, anti-ulcer drugs, anti-inflammatories, anti-epileptics, and anti-virals. Our staff of lawyers has experience and training in all aspects of chemistry and pharmaceuticals.

Representative Clients

  • Allergan
  • Amgen
  • Astellas
  • AstraZeneca
  • Bausch & Lomb
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Genzyme
  • Gilead
  • Kyowa Hakko
  • Novartis
  • Regeneron
  • Sanofi
  • Valeant